TD Asset Management’s NeoGenomics NEO Stock Holding History

TD Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-89,910	Closed	-$657K	–	1271
2025 Q2	$657K	Hold	89,910	–	–	﹤0.01%	1103
2025 Q1	$853K	Sell	89,910 -121,522	-57%	-$1.52M	﹤0.01%	1095
2024 Q4	$3.48M	Buy	211,432 +10,786	+5%	+$168K	﹤0.01%	858
2024 Q3	$2.91M	Sell	200,646 -3,000	-1%	-$46.9K	﹤0.01%	916
2024 Q2	$2.82M	Buy	203,646 +6,400	+3%	+$90.7K	﹤0.01%	895
2024 Q1	$3.1M	Buy	197,246 +13,246	+7%	+$205K	﹤0.01%	894
2023 Q4	$2.98M	Buy	184,000 +23,000	+14%	+$376K	﹤0.01%	883
2023 Q3	$1.98M	Buy	161,000 +19,600	+14%	+$291K	﹤0.01%	961
2023 Q2	$2.27M	Hold	141,400	–	–	﹤0.01%	934
2023 Q1	$2.46M	Buy	141,400 +57,200	+68%	+$815K	﹤0.01%	921
2022 Q4	$778K	Buy	84,200 +7,800	+10%	+$72.7K	﹤0.01%	1192
2022 Q3	$662K	Buy	+76,400	New	+$759K	﹤0.01%	1247

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

TD Asset Management's NEO Position: Q3 2025 in Review

TD Asset Management sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 89,910 shares — an estimated $657K sold.

TD Asset Management first reported a position in NEO in Q3 2022 and held it in 12 quarters. The position peaked at $3.48M in Q4 2024. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

TD Asset Management reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
TD Asset Management sold 89,910 NeoGenomics shares in Q3 2025, an estimated $657K.
TD Asset Management first reported a position in NeoGenomics in Q3 2022 and held it in 12 quarters.
TD Asset Management's NeoGenomics position peaked at $3.48M in Q4 2024.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on TD Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.